ED
Exane Derivatives’s HCA Healthcare HCA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | $26.4K | Hold |
157
| – | – | 0.02% | 352 |
|
2022
Q1 | $39.3K | Sell |
157
-321
| -67% | -$80.4K | 0.01% | 595 |
|
2021
Q4 | $123K | Sell |
478
-520
| -52% | -$134K | 0.03% | 414 |
|
2021
Q3 | $242K | Sell |
998
-23
| -2% | -$5.58K | 0.06% | 336 |
|
2021
Q2 | $224K | Sell |
1,021
-207
| -17% | -$45.4K | 0.05% | 358 |
|
2021
Q1 | $231K | Buy |
1,228
+40
| +3% | +$7.53K | 0.07% | 273 |
|
2020
Q4 | $195K | Buy |
1,188
+159
| +15% | +$26.1K | 0.06% | 307 |
|
2020
Q3 | $128K | Buy |
1,029
+38
| +4% | +$4.74K | 0.04% | 247 |
|
2020
Q2 | $96.2K | Sell |
991
-3,494
| -78% | -$339K | 0.03% | 283 |
|
2020
Q1 | $403K | Buy |
4,485
+4,467
| +24,817% | +$401K | 0.11% | 128 |
|
2019
Q4 | $2.65K | Buy |
18
+7
| +64% | +$1.03K | ﹤0.01% | 455 |
|
2019
Q3 | $1.32K | Hold |
11
| – | – | ﹤0.01% | 495 |
|
2019
Q2 | $1.49K | Sell |
11
-1
| -8% | -$135 | ﹤0.01% | 506 |
|
2019
Q1 | $1.56K | Sell |
12
-110
| -90% | -$14.3K | ﹤0.01% | 441 |
|
2018
Q4 | $15.2K | Sell |
122
-31,986
| -100% | -$3.98M | ﹤0.01% | 412 |
|
2018
Q3 | $4.47M | Buy |
32,108
+20,404
| +174% | +$2.84M | 0.84% | 18 |
|
2018
Q2 | $1.2M | Sell |
11,704
-356
| -3% | -$36.5K | 0.2% | 103 |
|
2018
Q1 | $1.17M | Buy |
+12,060
| New | +$1.17M | 0.23% | 106 |
|
2017
Q3 | – | Sell |
-26,094
| Closed | -$2.27M | – | 564 |
|
2017
Q2 | $2.27M | Sell |
26,094
-5,228
| -17% | -$456K | 0.49% | 42 |
|
2017
Q1 | $2.79M | Buy |
+31,322
| New | +$2.79M | 0.63% | 43 |
|
2016
Q3 | – | Sell |
-154,498
| Closed | -$11.9M | – | 586 |
|
2016
Q2 | $11.9M | Buy |
+154,498
| New | +$11.9M | 1.96% | 19 |
|
2015
Q3 | – | Sell |
-284,819
| Closed | -$25.8M | – | 496 |
|
2015
Q2 | $25.8M | Buy |
+284,819
| New | +$25.8M | 2.78% | 1 |
|